Regression of retinopathy by squalamine in a mouse model

Pediatric Research

Volumn 56, Issue 1, 2004, Pages 144-149

  Higgins, Rosemary D ^a,c   Yan, Yun ^a   Geng, Yixun ^a   Zasloff, Michael ^a   Williams, Jon I ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b Genaera Corporation   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SQUALAMINE;

ANIMAL MODEL; ARTICLE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; RETINOPATHY; SCORING SYSTEM; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANIMALS, NEWBORN; CHOLESTANOLS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT, NEWBORN; MICE; MICE, INBRED C57BL; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; TIME FACTORS;

EID: 3042634448     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000128977.55799.34     Document Type: Article

References (10)

1. Moore KS, Wehrli S, Roder H, Rogers M, Forrest Jr JN, McCrimmon D, Zasloff M 1993 Squalamine: an aminosterol antibiotic from the shark. Proc Natl Acad Sci U S A 90:1354-1358
2. Higgins RD, Sanders RJ, Yan Y, Zasloff M, Williams JI 2000 Squalamine improves retinal neovascularization. Invest Ophthalmol Vis Sci 41:1507-1512
3. Sills AK, Williams JI, Tyler BM, Epstein DS, Sipos EP, Davids JD, McLane MP, Pitchford S, Cheshire K, Gannon FH, Kinney WA, Chao TL, Donowitz M, Laterra J, Brem H 1998 Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res 58:2784-2792
4. Teicher BA, Williams JI, Takeuchi H, Ara G, Herbst RS, Buxton D 1998 Potential of the aminosterol squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma. Anticancer Res 18:2567-2573
5. Li D, Williams JI, Peitras RJ 2002 Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene 21:2805-2814
6. Genaidy M, Kazi AA, Peyman GA, Passos-Machado E, Farahat H, Williams JI, Holroyd K, Blake DA 2002 Effect of squalamine on iris neovascularization in monkeys. Retina 22:772-778
7. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA 1994 Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111
8. D'Amato R, Wesolowski E, Smith LE 1993 Microscopic visualization of the retina by angiography with high-molecular weight fluorescein-labeled dextrans in the mouse. Microvasc Res 46:135-142
9. Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB 1999 Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res 18:20-27
10. Bhargava P, Marshall JL, Dahut W, Rizvi N, Trocky N, Williams JI, Hait H, Song S, Holroyd KJ, Hawkins MJ 2001 A Phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers. Clin Can Res 7:3912-3919